The World Federation of Chinese Medicine Societies (WFCMS) recently released the Top 10 News on the world TCM. At the same time, the sponsor organized a Seminar on the Internationalization Process of TCM ". Leaders of Chinese National TCM Management Bureau and experts from TCM organization in Beijing attended the meeting. The conference was hosted by Vice President and Secretary of the WFCMS Li Zhenji.

As a representative enterprise of TCM internationalization, Tasly Holding Group was invited to attend the conference. Mr. Ye Zhengliang, Director of the International Industry center of Tasly, gave a presentation on the FDA application process of Caridotonic Dripping Pill (Dantonic )with the theme "creation, interaction and consensus-Dantonic Pill FDA IND Practices Sharing".

Mr. Ye reviewed the IND process of Dantonic and shared the information on the clinical applicability selection of FDAⅡclinical trial and the result analysis. He pointed out that the global phase III clinical trials of Dantonic had been carried out in hundreds of clinical centers in 9 countries and the trials were going on well without any adverse event related to the trail design or drug untill now, which indicated the safety of the drug and rationality of the trail design.


distributed by